Ramosetron hydrochloride
|
|
|
- CAS-Nr.
- 132907-72-3
- Englisch Name:
- Ramosetron hydrochloride
- Synonyma:
- ym060;Nasea OD;(R)-YM-060;RAMOSETRON HCL;YM-060;YM060;YM 060;(r)-monohydrochlorid;Ramosetron Hydrochlorid;Ramosetron hydrocloride;RAMOSETRON HYDROCHLORIDE;Ramosetron hydrochloride (API)
- CBNumber:
- CB1397525
- Summenformel:
- C17H18ClN3O
- Molgewicht:
- 315.8
- MOL-Datei:
- 132907-72-3.mol
|
Ramosetron hydrochloride Eigenschaften
- Schmelzpunkt:
- 244-246°C
- alpha
- D -42.9° (c 1.02 in methanol)
- storage temp.
- -20°C
- Löslichkeit
- H2O: soluble20mg/mL, clear
- Aggregatzustand
- powder
- Farbe
- white to beige
- Optische Aktivität
- [α]/D -40 to -45°, c = 1 in methanol
- Stabilität:
- Hygroscopic
- InChIKey
- XIXYTCLDXQRHJO-RFVHGSKJSA-N
- CAS Datenbank
- 132907-72-3(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| Kennzeichnung gefährlicher |
Xn |
|
|
| R-Sätze: |
22 |
|
|
| WGK Germany |
3 |
|
|
| Toxizität |
dog,LD,intravenous,> 30mg/kg (30mg/kg),SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE,Oyo Yakuri. Pharmacometrics. Vol. 47, Pg. 117, 1994. |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitsschädlich bei Verschlucken. |
Akute Toxizität oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
| Sicherheit |
|
Ramosetron hydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Ramosetron Hydrochloride is the only currently available drug indicated for the treatment of male patients with IBS-D in Japan. Ramosetron Hydrochloride was approved in July 1996 under a brand name of Nasea Injection 0.3 mg and in June 1998 under a brand name of Nasea OD tablets 0.1 mg for the treatment of gastrointestinal symptoms (nausea and vomiting) associated with therapy with antineoplastic drugs (e.g., cisplatin).
Nasea was launched in Japan for chemotherapy-induced emesis. Nasea was prepared by a four step sequence via the Vilsmeier-type coupling of 1-methylindole and 5-( 1- pyrrolidoncarbonyl)-4,5,6,7-tetrahydro-Hl-benzimidazole hydrochloride. The antiemetic activity arises because it is a potent 5-HT3 receptor antagonist that is i.v. and orally active. The (R)-isomer was found to be 100 times more potent than the (S)-isomer. It was able to inhibit cisplatin-induce emesis and was 8670 times more potent than netoclopramide.
Chemische Eigenschaften
White Solid
Verwenden
Ramosetron Hydrochloride is a selective serotonin 5-HT3 receptor antagonist and has structurally different from Ondansetron (O655000), Granisetron (G780000). It controls excessive bowel movement and diarrhea by inhibiting 5-HT3 receptors in the intestinal tract. Ramosetron Hydrochloride was approved as film-coated tablets in July 2008 and as orally disintegrating tablets in August 2013 for the indication of treatment of male patients with diarrhea-predominant irritable bowel syndrome.
Ramosetron hydrochloride Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Ramosetron hydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 254)Lieferanten
132907-72-3()Verwandte Suche:
- Methanone,(1-Methyl-1H-indol-3-yl)[(6R)-4,5,6,7-tetrahydro-1H-benziMidazol-6-yl]-,hydrochloride (1:1)
- (R)-5-[(1-Methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride
- (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone hydrochloride
- RAMOSETRON HCL
- RAMOSETRON HYDROCHLORIDE
- (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-methanon
- (r)-5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazolehydr
- (r)-monohydrochlorid
- ym060
- RAMOSETRON HYDROCHLORIDE 98.5% MIN
- (-)-5-(R)-[(1-methylindole-3-yl)carbonyl]-4,5,6,7-tetrahydrobenzimidazole hydrochloride
- Ramosetron Hydrochlorid
- Methanone, (1-methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzimidazol-5-yl)-, monohydrochloride, (R)-
- Methanone, (1-methyl-1H-indol-3-yl)[(5R)-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]-, monohydrochloride (9CI)
- (R)-YM-060
- Nasea OD
- (R)-(1-Methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzo[d]iMidazol-6-yl)Methanone hydrochloride
- (1-Methyl-1H-indol-3-yl)[(6R)-4,5,6,7-tetrahydro-1H-benziMidazol-6-yl]Methanone
- (1-methyl-3-indolyl)-(4,5,6,7-tetrahydro-3H-benzimidazol-5-yl)methanone hydrochloride
- (1-METHYL-1H-INDOL-3-YL)[(5R)-4,5,6,7-TETRAHYDRO-1H-BENZIMIDAZOL-5-YL]METHANONE
- Ramosetron hydrocloride
- YM-060;YM060;YM 060
- Ramosetron HydrochlorideQ: What is
Ramosetron Hydrochloride Q: What is the CAS Number of
Ramosetron Hydrochloride Q: What is the storage condition of
Ramosetron Hydrochloride Q: What are the applications of
Ramosetron Hydrochloride
- Ramosetron hydrochloride (API)
- 132907-72-3
- C17H17N3OHCl
- C17H17N3OClH
- API
- Antiemetic
- Chiral Reagents
- Heterocycles
- Intermediates & Fine Chemicals
- Pharmaceuticals
- 132907-72-3
